Tsutomu Yoshida Selected Research

MVP protocol 2

10/2003

[Lung toxicity of trimodality chemoradiotherapy with mitomycin C, vindesine, and cisplatin followed by surgery for locally advanced non-small cell lung cancer].

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Tsutomu Yoshida Research Topics

Disease

22	Neoplasms (Cancer) 01/2022 - 11/2002
11	Ulcerative Colitis 08/2020 - 10/2002
10	Carcinoma (Carcinomatosis) 01/2020 - 03/2002
9	Adenocarcinoma 12/2022 - 05/2003
9	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 01/2016 - 10/2003
5	Lung Neoplasms (Lung Cancer) 08/2019 - 01/2003
4	Adenocarcinoma of Lung 03/2021 - 09/2006
4	Colorectal Neoplasms (Colorectal Cancer) 08/2020 - 01/2009
4	Colitis 03/2019 - 10/2002
4	Carcinogenesis 08/2012 - 10/2003
4	Adenoma (Adenomas) 05/2011 - 05/2003
3	Lymphatic Metastasis 09/2021 - 11/2011
3	Endometrial Neoplasms (Endometrial Cancer) 11/2013 - 01/2003
2	Stomach Neoplasms (Stomach Cancer) 12/2022 - 10/2017
2	Microsatellite Instability 01/2022 - 10/2003
2	Disease Progression 05/2021 - 01/2010
2	Hypoxia (Hypoxemia) 08/2020 - 11/2013
2	Lymphoma (Lymphomas) 05/2020 - 01/2010
2	Leukopenia 10/2017 - 01/2003
2	Follicular Lymphoma (Lymphoma, Small Cleaved Cell, Follicular) 06/2015 - 01/2010
2	Hyperplasia 01/2014 - 01/2003
2	Radiation Pneumonitis 11/2013 - 11/2010
2	Pulmonary Fibrosis (Fibrosing Alveolitis) 11/2013 - 11/2010
2	Metabolic Syndrome (Dysmetabolic Syndrome X) 08/2012 - 03/2011
1	Rectal Neoplasms (Rectal Cancer) 01/2022
1	Pathologic Complete Response 01/2022
1	Esophageal Neoplasms (Esophageal Cancer) 12/2021
1	Triple Negative Breast Neoplasms 09/2021
1	Breast Neoplasms (Breast Cancer) 09/2021
1	Multiple Myeloma 05/2021
1	Sarcoidosis (Schaumann Disease) 01/2021
1	Lymphadenopathy 01/2021
1	Pancreatic Neoplasms (Pancreatic Cancer) 04/2019
1	Ulcer 03/2019
1	Vomiting 01/2019
1	Nausea 01/2019
1	Granuloma 01/2019
1	Inflammation (Inflammations) 02/2018

Drug/Important Bio-Agent (IBA)

9	Proteins (Proteins, Gene)FDA Link 03/2019 - 03/2002
7	ErbB Receptors (EGF Receptor)IBA 03/2021 - 09/2006
4	DNA (Deoxyribonucleic Acid)IBA 03/2021 - 02/2003
4	Formaldehyde (Formol)FDA Link 04/2019 - 01/2006
4	Messenger RNA (mRNA)IBA 03/2019 - 01/2006
3	Amino Acid Transport Systems (Amino Acid Transporter)IBA 09/2021 - 05/2011
3	ParaffinIBA 04/2019 - 01/2006
3	Dextran SulfateIBA 03/2019 - 10/2002
3	Carboplatin (JM8)FDA LinkGeneric 01/2019 - 03/2009
3	beta CateninIBA 04/2011 - 01/2003
2	B7-H1 AntigenIBA 12/2022 - 01/2018
2	Progesterone Receptors (Progesterone Receptor)IBA 09/2021 - 01/2003
2	Dexamethasone (Maxidex)FDA LinkGeneric 05/2021 - 01/2019
2	AntigensIBA 02/2019 - 04/2011
2	Keratins (Keratin)IBA 01/2018 - 01/2009
2	Cadherins (E-Cadherin)IBA 01/2018 - 03/2007
2	Cisplatin (Platino)FDA LinkGeneric 10/2017 - 10/2003
2	Tyrosine Kinase InhibitorsIBA 01/2015 - 01/2004
2	Cyclin D1IBA 01/2014 - 01/2006
2	Biomarkers (Surrogate Marker)IBA 01/2014 - 12/2008
2	CateninsIBA 01/2014 - 11/2013
2	Cyclin EIBA 01/2014 - 01/2006
2	Transcription Factors (Transcription Factor)IBA 08/2012 - 01/2010
2	Butyric Acid (Butanoic Acid)IBA 03/2011 - 03/2006
2	NF-kappa B (NF-kB)IBA 01/2010 - 05/2009
2	CytokinesIBA 05/2009 - 08/2006
1	pembrolizumabIBA 12/2022
1	NivolumabIBA 01/2022
1	LigandsIBA 01/2022
1	human ERBB2 proteinIBA 09/2021
1	Bortezomib (Velcade)FDA Link 05/2021
1	Peptidyl-Dipeptidase A (Angiotensin Converting Enzyme)IBA 01/2021
1	Fluorodeoxyglucose F18 (Fludeoxyglucose F 18)FDA Link 01/2021
1	Interleukin-2 Receptors (IL 2 Receptor)IBA 01/2021
1	Carbonic Anhydrases (Carbonic Anhydrase)IBA 08/2020
1	Microtubule-Associated Proteins (Microtubule-Associated Protein 2)IBA 05/2020
1	Protein Kinases (Protein Kinase)IBA 05/2020
1	MucinsIBA 07/2019
1	Protein-Tyrosine Kinases (Tyrosine Kinase)IBA 03/2019
1	Vascular Endothelial Growth Factor Receptor-1 (fms-Like Tyrosine Kinase)IBA 03/2019
1	CarbohydratesIBA 02/2019
1	5-HT3 Serotonin Receptors (5 HT3 Receptor)IBA 01/2019
1	Peptides (Polypeptides)IBA 01/2019
1	Neurokinin-1 Receptor AntagonistsIBA 01/2019
1	angiogeninIBA 01/2019
1	Olanzapine (Zyprexa)FDA Link 01/2019
1	Granisetron (Kytril)FDA LinkGeneric 01/2019
1	A-Form DNA (A-DNA)IBA 12/2018
1	SolutionsIBA 12/2018
1	ThioredoxinsIBA 02/2018
1	ProteomeIBA 02/2018
1	PeroxiredoxinsIBA 02/2018

Therapy/Procedure

8	Therapeutics 05/2021 - 01/2003
7	Drug Therapy (Chemotherapy) 08/2019 - 01/2003
5	Radiotherapy 01/2016 - 10/2003
4	Chemoradiotherapy 01/2022 - 10/2003
4	Lasers (Laser) 01/2009 - 10/2003
2	Combination Drug Therapy (Combination Chemotherapy) 10/2017 - 03/2009
1	Laryngoscopes 12/2021
1	Ligation 04/2019
1	Precision Medicine 04/2019
1	Operative Surgical Procedures 12/2018